Accordingly, it was suggested that the rescue of these intrahepatic CD4+ T cells from apoptosis might prevent tumor initiation and aid in immunotherapy for NAFLD-promoted HCC [3,13]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.